论文部分内容阅读
英国伦敦消息:胸腺的许多提取物和各种合成的胸腺素用于治疗各种晚期的顽固性肿瘤获得了显著的效果。肿瘤病人经许多药物治疗、放射治疗或外科手术后,体内T淋巴细胞的免疫防御功能受损,应用胸腺因子可能增加T细胞的增殖和活性。乔治·华盛顿大学医学中心的RichardS Schulof说,合成均胸腺素α-1使28例晚期非小细胞肺癌病人的平均复发期推迟到30周,而在13名给予安慰剂的病人中,平均复发期为
London, UK Message: Many extracts of the thymus and various synthetic thymosins have been used to treat a variety of advanced refractory tumors. The immune defense function of T lymphocytes in vivo is impaired in patients with cancer after many drug treatments, radiation therapy or surgery. The application of thymic factors may increase the proliferation and activity of T cells. Richard S Schulof, George Washington University Medical Center, said that synthetic thymosin alpha-1 delayed the mean recurrence of 28 patients with advanced non-small cell lung cancer to 30 weeks, compared with an average of 13 patients who received placebo. for